StockNews.com upgraded shares of Baozun (NASDAQ:BZUN – Free Report) from a hold rating to a buy rating in a research report sent to investors on Sunday. Separately, Citigroup upped their price ...

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has received a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports ...

Shares of German American Bancorp, Inc. (NASDAQ:GABC – Get Free Report) have earned an average rating of “Moderate Buy” from the five brokerages that are presently covering the stock, Marketbeat ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat reports.

Investment analysts at William Blair reduced their Q1 2025 earnings per share (EPS) estimates for shares of Forrester Research in a note issued to investors on Wednesday, February 12th. William Blair ...

Alerus Financial Co. (NASDAQ:ALRS – Get Free Report) has received a consensus rating of “Hold” from the five ratings firms that are covering the firm, MarketBeat.com reports. Three investment analysts ...

JFrog (NASDAQ:FROG – Get Free Report) had its price objective upped by research analysts at Stifel Nicolaus from $35.00 to $45.00 in a research report issued to clients and investors on ...

Cohu, Inc. (NASDAQ:COHU – Get Free Report) shares gapped down prior to trading on Friday after B. Riley lowered their price target on the stock from $34.00 to $30.00. The stock had previously closed ...

We recently compiled a list of the 12 Best Consumer Discretionary Stocks to Buy According to Analysts. In this article, we ...

We recently compiled a list of the 13 Best Forever Stocks to Buy Right Now. In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against the other forever stocks.

D. Boral Capital reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Wednesday morning,Benzinga reports. D. Boral Capital currently has a ...

Analysts at Wedbush decreased their FY2025 EPS estimates for Voyager Therapeutics in a research note issued on Tuesday, ...